ID   CMGA_RAT                Reviewed;         466 AA.
AC   P10354;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   07-APR-2021, entry version 132.
DE   RecName: Full=Chromogranin-A;
DE            Short=CgA;
DE   Contains:
DE     RecName: Full=Pancreastatin;
DE   Contains:
DE     RecName: Full=Beta-granin;
DE   Contains:
DE     RecName: Full=WE-14;
DE   Contains:
DE     RecName: Full=Catestatin;
DE   Contains:
DE     RecName: Full=GE-25;
DE   Contains:
DE     RecName: Full=Serpinin-RRG {ECO:0000303|PubMed:22459152};
DE   Contains:
DE     RecName: Full=Serpinin {ECO:0000303|PubMed:22459152};
DE   Contains:
DE     RecName: Full=p-Glu serpinin precursor;
DE   Flags: Precursor;
GN   Name=Chga;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2828116; DOI=10.1016/0014-5793(88)80880-9;
RA   Iacangelo A., Okayama H., Eiden L.E.;
RT   "Primary structure of rat chromogranin A and distribution of its mRNA.";
RL   FEBS Lett. 227:115-121(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 29-466.
RC   TISSUE=Pancreas;
RX   PubMed=3044825; DOI=10.1016/0014-5793(88)80036-x;
RA   Hutton J.C., Nielsen E., Kastern W.;
RT   "The molecular cloning of the chromogranin A-like precursor of beta-granin
RT   and pancreastatin from the endocrine pancreas.";
RL   FEBS Lett. 236:269-274(1988).
RN   [3]
RP   PROTEIN SEQUENCE OF 19-32.
RX   PubMed=3896848; DOI=10.1016/0014-5793(85)80398-7;
RA   Hutton J.C., Hansen F., Peshavaria M.;
RT   "Beta-granins: 21 kDa co-secreted peptides of the insulin granule closely
RT   related to adrenal medullary chromogranin A.";
RL   FEBS Lett. 188:336-340(1985).
RN   [4]
RP   INTERACTION WITH SCG3, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12388744; DOI=10.1091/mbc.02-03-0040;
RA   Hosaka M., Watanabe T., Sakai Y., Uchiyama Y., Takeuchi T.;
RT   "Identification of a chromogranin A domain that mediates binding to
RT   secretogranin III and targeting to secretory granules in pituitary cells
RT   and pancreatic beta-cells.";
RL   Mol. Biol. Cell 13:3388-3399(2002).
RN   [5]
RP   SUBCELLULAR LOCATION.
RX   PubMed=14597614; DOI=10.1074/jbc.m310104200;
RA   Hosaka M., Suda M., Sakai Y., Izumi T., Watanabe T., Takeuchi T.;
RT   "Secretogranin III binds to cholesterol in the secretory granule membrane
RT   as an adapter for chromogranin A.";
RL   J. Biol. Chem. 279:3627-3634(2004).
RN   [6]
RP   IDENTIFICATION OF SERPININ PEPTIDE; SERPININ-RRG PEPTIDE AND
RP   PYROGLUTAMINATED SERPININ, FUNCTION (SERPININ), AND PYROGLUTAMATE FORMATION
RP   AT GLN-441.
RX   PubMed=22459152; DOI=10.1096/fj.11-201111;
RA   Tota B., Gentile S., Pasqua T., Bassino E., Koshimizu H., Cawley N.X.,
RA   Cerra M.C., Loh Y.P., Angelone T.;
RT   "The novel chromogranin A-derived serpinin and pyroglutaminated serpinin
RT   peptides are positive cardiac beta-adrenergic-like inotropes.";
RL   FASEB J. 26:2888-2898(2012).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312; SER-353; SER-386;
RP   SER-417; SER-433 AND SER-447, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=29166604; DOI=10.1016/j.celrep.2017.10.084;
RA   Bharat V., Siebrecht M., Burk K., Ahmed S., Reissner C.,
RA   Kohansal-Nodehi M., Steubler V., Zweckstetter M., Ting J.T., Dean C.;
RT   "Capture of Dense Core Vesicles at Synapses by JNK-Dependent
RT   Phosphorylation of Synaptotagmin-4.";
RL   Cell Rep. 21:2118-2133(2017).
CC   -!- FUNCTION: [Pancreastatin]: Strongly inhibits glucose induced insulin
CC       release from the pancreas.
CC   -!- FUNCTION: Catestatin inhibits catecholamine release from chromaffin
CC       cells and noradrenergic neurons by acting as a non-competitive
CC       nicotinic cholinergic antagonist. Can induce mast cell migration,
CC       degranulation and production of cytokines and chemokines.
CC       {ECO:0000250|UniProtKB:P10645}.
CC   -!- FUNCTION: Serpinin regulates granule biogenesis in endocrine cells by
CC       up-regulating the transcription of protease nexin 1 (SERPINE2) via a
CC       cAMP-PKA-SP1 pathway. This leads to inhibition of granule protein
CC       degradation in the Golgi complex which in turn promotes granule
CC       formation (By similarity). Serpinin and pGlu-serpinin can enhance both
CC       myocardial contractility (inotropy) and relaxation (lusitropy) and this
CC       cardio-stimulation requires a beta 1-adrenergic receptor/adenylate
CC       cyclase/cAMP/PKA pathway (PubMed:22459152).
CC       {ECO:0000250|UniProtKB:P26339, ECO:0000269|PubMed:22459152}.
CC   -!- SUBUNIT: Interacts with SCG3; this interaction is optimal in conditions
CC       mimicking the lumenal milieu of the trans-Golgi network, i.e. pH 5.5
CC       and 10 mM Ca(+2). {ECO:0000269|PubMed:12388744}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle
CC       {ECO:0000269|PubMed:12388744, ECO:0000269|PubMed:3896848}. Cytoplasmic
CC       vesicle, secretory vesicle, neuronal dense core vesicle
CC       {ECO:0000269|PubMed:29166604}. Secreted. Note=Associated with the
CC       secretory granule membrane through direct interaction to SCG3 that in
CC       turn binds to cholesterol-enriched lipid rafts in intragranular
CC       conditions. In pituitary gonadotropes, located in large secretory
CC       granules.
CC   -!- SUBCELLULAR LOCATION: [Serpinin]: Secreted
CC       {ECO:0000250|UniProtKB:P26339}. Cytoplasmic vesicle, secretory vesicle
CC       {ECO:0000250|UniProtKB:P26339}. Note=Pyroglutaminated serpinin
CC       localizes to secretory vesicle. {ECO:0000250|UniProtKB:P26339}.
CC   -!- TISSUE SPECIFICITY: Expressed in the brain and adrenal and pituitary
CC       glands. {ECO:0000269|PubMed:12388744}.
CC   -!- PTM: CgA is O-glycosylated.
CC   -!- MISCELLANEOUS: Binds calcium with a low-affinity.
CC   -!- SIMILARITY: Belongs to the chromogranin/secretogranin protein family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X06832; CAA29988.1; -; mRNA.
DR   PIR; A23996; A23996.
DR   SMR; P10354; -.
DR   iPTMnet; P10354; -.
DR   PhosphoSitePlus; P10354; -.
DR   jPOST; P10354; -.
DR   PRIDE; P10354; -.
DR   RGD; 2338; Chga.
DR   InParanoid; P10354; -.
DR   PhylomeDB; P10354; -.
DR   Reactome; R-RNO-6803157; Antimicrobial peptides.
DR   PRO; PR:P10354; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0042583; C:chromaffin granule; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0098992; C:neuronal dense core vesicle; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0030141; C:secretory granule; IDA:RGD.
DR   GO; GO:0030133; C:transport vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0086030; P:adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation; IDA:UniProtKB.
DR   GO; GO:0042742; P:defense response to bacterium; IBA:GO_Central.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; ISS:UniProtKB.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; ISS:UniProtKB.
DR   GO; GO:0045576; P:mast cell activation; ISS:UniProtKB.
DR   GO; GO:0002551; P:mast cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0043303; P:mast cell degranulation; ISS:UniProtKB.
DR   GO; GO:0033604; P:negative regulation of catecholamine secretion; ISS:UniProtKB.
DR   GO; GO:0046676; P:negative regulation of insulin secretion; IBA:GO_Central.
DR   GO; GO:1901215; P:negative regulation of neuron death; IDA:RGD.
DR   GO; GO:0006996; P:organelle organization; IMP:RGD.
DR   GO; GO:0042698; P:ovulation cycle; IEP:RGD.
DR   GO; GO:0043950; P:positive regulation of cAMP-mediated signaling; IDA:RGD.
DR   GO; GO:0060452; P:positive regulation of cardiac muscle contraction; IDA:UniProtKB.
DR   GO; GO:2000707; P:positive regulation of dense core granule biogenesis; ISS:UniProtKB.
DR   GO; GO:1900738; P:positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:RGD.
DR   GO; GO:1901899; P:positive regulation of relaxation of cardiac muscle; IDA:UniProtKB.
DR   GO; GO:0033366; P:protein localization to secretory granule; ISO:RGD.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IDA:RGD.
DR   GO; GO:0002026; P:regulation of the force of heart contraction; IDA:RGD.
DR   InterPro; IPR001819; Chromogranin_AB.
DR   InterPro; IPR018054; Chromogranin_CS.
DR   InterPro; IPR001990; Granin.
DR   PANTHER; PTHR10583; PTHR10583; 1.
DR   Pfam; PF01271; Granin; 2.
DR   PRINTS; PR00659; CHROMOGRANIN.
DR   PROSITE; PS00422; GRANINS_1; 1.
DR   PROSITE; PS00423; GRANINS_2; 1.
PE   1: Evidence at protein level;
KW   Amidation; Calcium; Cleavage on pair of basic residues;
KW   Cytoplasmic vesicle; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Oxidation; Phosphoprotein; Pyrrolidone carboxylic acid;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000269|PubMed:3896848"
FT   CHAIN           19..466
FT                   /note="Chromogranin-A"
FT                   /id="PRO_0000005430"
FT   PEPTIDE         19..146
FT                   /note="Beta-granin"
FT                   /id="PRO_0000005431"
FT   PEPTIDE         281..332
FT                   /note="Pancreastatin"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000005432"
FT   PEPTIDE         361..374
FT                   /note="WE-14"
FT                   /id="PRO_0000005433"
FT   PEPTIDE         385..405
FT                   /note="Catestatin"
FT                   /evidence="ECO:0000250|UniProtKB:P10645"
FT                   /id="PRO_0000432697"
FT   PEPTIDE         408..426
FT                   /note="GE-25"
FT                   /evidence="ECO:0000250|UniProtKB:P05059"
FT                   /id="PRO_0000432698"
FT   PEPTIDE         438..466
FT                   /note="Serpinin-RRG"
FT                   /evidence="ECO:0000269|PubMed:22459152"
FT                   /id="PRO_0000432699"
FT   PEPTIDE         438..463
FT                   /note="Serpinin"
FT                   /evidence="ECO:0000269|PubMed:22459152"
FT                   /id="PRO_0000432700"
FT   PEPTIDE         441..463
FT                   /note="p-Glu serpinin precursor"
FT                   /evidence="ECO:0000250|UniProtKB:P26339"
FT                   /id="PRO_0000432701"
FT   COMPBIAS        92..110
FT                   /note="Poly-Gln"
FT   COMPBIAS        231..249
FT                   /note="Poly-Glu"
FT   COMPBIAS        344..350
FT                   /note="Poly-Glu"
FT   MOD_RES         114
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P05059"
FT   MOD_RES         215
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P10645"
FT   MOD_RES         288
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P26339"
FT   MOD_RES         312
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         332
FT                   /note="Glycine amide"
FT                   /evidence="ECO:0000250|UniProtKB:P05059"
FT   MOD_RES         353
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         386
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         387
FT                   /note="Methionine sulfoxide"
FT                   /evidence="ECO:0000250|UniProtKB:P10645"
FT   MOD_RES         413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P05059"
FT   MOD_RES         417
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         433
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         441
FT                   /note="Pyrrolidone carboxylic acid"
FT                   /evidence="ECO:0000250|UniProtKB:P26339,
FT                   ECO:0000303|PubMed:22459152"
FT   MOD_RES         447
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   DISULFID        35..56
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   466 AA;  52024 MW;  05D135FFA657C48C CRC64;
     MRSSAALALL LCAGQVFALP VNSPMTKGDT KVMKCVLEVI SDSLSKPSPM PVSPECLETL
     QGDERVLSIL RHQNLLKELQ DLALQGAKER AQQQQQQQQQ QQQQQQQQQQ QHSSFEDELS
     EVFENQSPAA KHGDAASEAP SKDTVEKRED SDKGQQDAFE GTTEGPRPQA FPEPKQESSM
     MGNSQSPGED TANNTQSPTS LPSQEHGIPQ TTEGSERGPS AQQQARKAKQ EEKEEEEEEK
     EEEEEEKEEK AIAREKAGPK EVPTAASSSH FYSGYKKIQK DDDGQSESQA VNGKTGASEA
     VPSEGKGELE HSQQEEDGEE AMAGPPQGLF PGGKGQELER KQQEEEEEEE RLSREWEDKR
     WSRMDQLAKE LTAEKRLEGE DDPDRSMKLS FRARAYGFRD PGPQLRRGWR PSSREDSVEA
     RGDFEEKKEE EGSANRRAED QELESLSAIE AELEKVAHQL QALRRG
//
